For help on how to get the results you want, see our search tips.
2667 results
Medicine
Direct healthcare professional communication Remove Direct healthcare professional communication filter
Paediatric investigation plans Remove Paediatric investigation plans filter
Summaries of opinion Remove Summaries of opinion filter
Categories
Human Remove Human filter
-
List item
Summary of opinion: Tidhesco
ivosidenib, opinion date: 23/02/2023, Positive, Last updated: 24/02/2023 -
List item
Summary of opinion: Opzelura
ruxolitinib, opinion date: 23/02/2023, Positive, Last updated: 24/02/2023 -
List item
Summary of opinion: Elfabrio
pegunigalsidase alfa, opinion date: 23/02/2023, Positive, Last updated: 24/02/2023 -
List item
Summary of opinion: Vafseo
vadadustat, opinion date: 23/02/2023, Positive, Last updated: 24/02/2023 -
List item
Summary of opinion: Libtayo
cemiplimab, opinion date: 23/02/2023, Positive, Last updated: 24/02/2023 -
List item
Summary of opinion: Bekemv
eculizumab, opinion date: 23/02/2023, Positive, Last updated: 24/02/2023 -
List item
Summary of opinion: Hyftor
sirolimus, opinion date: 23/02/2023, Positive, Last updated: 24/02/2023 -
List item
Summary of opinion: Esbriet
pirfenidone, opinion date: 23/02/2023, Positive, Last updated: 24/02/2023 -
List item
Summary of opinion: Akeega
niraparib, abiraterone acetate, opinion date: 23/02/2023, Positive, Last updated: 24/02/2023 -
List item
Summary of opinion: Imcivree
setmelanotide, opinion date: 21/07/2022, Positive, Last updated: 22/07/2022 -
List item
Summary of opinion: Vegzelma
bevacizumab, opinion date: 23/06/2022, Positive, Last updated: 21/06/2022 -
List item
Summary of opinion: Newflend ND H9 (new)
turkey herpes virus, strain rHVT/ND expressing Newcastle disease virus, live, opinion date: 23/03/2023, Positive, Last updated: 24/03/2023 -
List item
Summary of opinion: Comirnaty
tozinameran, riltozinameran and tozinameran, famtozinameran and tozinameran, COVID-19 mRNA Vaccine (nucleoside modified), opinion date: 19/10/2022, Positive, Last updated: 19/10/2022 -
List item
Summary of opinion: Rinvoq
upadacitinib, opinion date: 23/02/2023, Positive, Last updated: 24/02/2023 -
List item
Summary of opinion: Omvoh (new)
mirikizumab, opinion date: 30/03/2023, Positive, Last updated: 31/03/2023 -
List item
Summary of opinion: Lacosamide Adroiq (new)
lacosamide, opinion date: 30/03/2023, Positive, Last updated: 31/03/2023 -
List item
Summary of opinion: Breyanzi (new)
lisocabtagene maraleucel, opinion date: 30/03/2023, Positive, Last updated: 31/03/2023 -
List item
Summary of opinion: Epysqli (new)
opinion date: 30/03/2023, Positive, Last updated: 31/03/2023 -
List item
Summary of opinion: Briumvi (new)
ublituximab, opinion date: 30/03/2023, Positive, Last updated: 31/03/2023 -
List item
Summary of opinion: Pedmarqsi (new)
sodium thiosulfate, opinion date: 30/03/2023, Positive, Last updated: 31/03/2023 -
List item
Summary of opinion: Ultomiris (new)
ravulizumab, opinion date: 30/03/2023, Positive, Last updated: 31/03/2023 -
List item
Summary of opinion: Ultomiris (new)
ravulizumab, opinion date: 30/03/2023, Positive, Last updated: 31/03/2023 -
List item
Summary of opinion: Entresto (new)
sacubitril, valsartan, opinion date: 30/03/2023, Positive, Last updated: 31/03/2023 -
List item
Summary of opinion: Tenkasi (previously Orbactiv) (new)
oritavancin, opinion date: 30/03/2023, Positive, Last updated: 31/03/2023 -
List item
Summary of opinion: Sugammadex Adroiq (new)
sugammadex, opinion date: 30/03/2023, Positive, Last updated: 31/03/2023